• AAPL 169.3
  • TSLA 168.29
  • AMZN 179.62
  • MSFT 406.32
  • INTC 31.88
  • EURUSD 1.0696
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. BIOVF.PINK

Swedish Orphan Biovitrum AB (publ) (BIOVF PINK) stock market data APIs

$22.87 0(0%) as of April 25, 2024

Swedish Orphan Biovitrum AB (publ) Financial Data Overview

22.87
22.87
-
22.87
22.87
18.35-27.79
8 368 M
33.6324
340 M
22 123 M
0.2805
0.265
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BIOVF',
Type: 'Common Stock',
Name: 'Swedish Orphan Biovitrum AB (publ)',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000TXX874',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: NULL,
IsDelisted: false,
}

Swedish Orphan Biovitrum AB (publ) Fundamental Data is available in our Financial Data APIs

  • Net Revenue 22 123 M
  • EBITDA 7 548 M
  • Earnings Per Share 0.68
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Swedish Orphan Biovitrum AB (publ) Earnings via APIs

  • Latest Release 2023-12-31
  • EPS/Forecast NaN

Get Swedish Orphan Biovitrum AB (publ) End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Swedish Orphan Biovitrum AB (publ) latest news via APIs

Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio

STOCKHOLM, April 25, 2024 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 2...

Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024

STOCKHOLM, Feb. 8, 2024 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2023. Fourth Quarter 2023 Total revenue increased 14 per cent, ...
Do you have any questions?
support@eodhistoricaldata.com